Incyte (INCY) Other Operating Expenses (2012 - 2026)

Incyte (INCY) posted Other Operating Expenses of $127.6 million for Q1 2026, down 47.34% on a QoQ basis from $242.3 million in Q2 2025, and up 50.51% year-over-year from $84.8 million in Q1 2025.

Incyte (INCY) Other Operating Expenses (2012 - 2026) Analysis & Trends

Incyte's Other Operating Expenses history runs 15 years deep, the most recent figure standing at $127.6 million for Q1 2026.

  • Quarterly Other Operating Expenses rose 50.51% year-over-year to $127.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $369.8 million (up 336.31% YoY) and the FY2025 annual result came in at $242.3 million, changed N/A from the prior year.
  • Other Operating Expenses was $127.6 million for Q1 2026 at Incyte, down from $242.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $242.3 million in Q2 2025 and bottomed at $34.5 million in Q3 2022.
  • A 5-year average of $86.1 million and a median of $68.9 million in 2023 frame the typical range for Other Operating Expenses.
  • Annual changes were most pronounced in 2022 — Other Operating Expenses sank 33.64% — and 2023, when it jumped 76.2%.
  • Incyte's Other Operating Expenses stood at $82.4 million in 2022, then advanced by 13.24% to $93.3 million in 2023, then tumbled by 36.28% to $59.5 million in 2024, then jumped by 307.32% to $242.3 million in 2025, then slumped by 47.34% to $127.6 million in 2026.
  • Business Quant data shows INCY's Other Operating Expenses at $127.6 million in Q1 2026, $242.3 million in Q2 2025, and $84.8 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 127.57 Mn
Jun 30, 2025 242.25 Mn
Mar 31, 2025 84.76 Mn
Mar 31, 2024 59.48 Mn
Dec 31, 2023 93.34 Mn
Sep 30, 2023 60.72 Mn
Jun 30, 2023 76.15 Mn
Mar 31, 2023 61.66 Mn
Dec 31, 2022 82.43 Mn
Sep 30, 2022 34.46 Mn
Jun 30, 2022 56.49 Mn
Mar 31, 2022 53.74 Mn
Dec 31, 2021 53.09 Mn
Sep 30, 2021 51.93 Mn
Jun 30, 2021 52.50 Mn
Mar 31, 2021 45.23 Mn
Dec 31, 2020 52.35 Mn
Sep 30, 2020 56.42 Mn
Jun 30, 2020 52.67 Mn
Mar 31, 2020 36.08 Mn